ESR1 and breast cancer: Our study revealed that ER+/PR−/HER2− breast cancers of cluster 3 had the highest level of infiltration by immune effectors such as CD8+ T and NK cells, and elevated expression of IFN-γ response and cytolytic activity signatures.